Novartis to Acquire Presbyopia Drug Developer Encore Vision
Wednesday, December 21 2016 | 00 h 00 min | News
Novartis Ophthalmology announced they have entered into an agreement to acquire a topical treatment for presbyopia from Encore Vision Inc, a...
Read More
